News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Percheron Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
Health & Biotech
The surge and plunge in ASX biotech shows what the FDA giveth, the FDA taketh away
News
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study
News
Last Orders: Small caps dip again, but infant formula makers rise
News
Last Orders: Small caps rebound to finish day flat
Experts
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
Health & Biotech
Check Up: Eco-fibre play Nanollose leads ASX healthcare sector with 292% gain
Experts
ScoPo’s powerplays: Searching for gems as healthcare sector languishes
News
Closing Bell: Today’s biggest small cap movers on the ASX
Experts
ScoPo’s Powerplays: Despite recent losses, healthcare is a great sector to be in
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Antisense Therapeutics receives FDA orphan designation for muscular dystrophy treatment
Experts
ScoPo’s Powerplays: Healthcare companies raised $1bn year-to-date
Experts
ScoPo’s Health Powerplays: Biotechs hitting it out of the park
Health & Biotech
Antisense’s DMD drug could have ‘profound’ impact on boys
News
Closing Bell: Today’s biggest small cap movers on the ASX
News